Innoviva Inc reports results for the quarter ended September 30 - Earnings Summary

• Innoviva Inc INVA.OQ reported quarterly adjusted earnings of $1.08​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of 26 cents. The mean expectation of four analysts for the quarter was for earnings of 55 cents per share. Wall Street expected results to range from 19 cents to $1.30 per share.

• Revenue rose 28% to $107.80 million from a year ago; analysts expected $102.62 million.

• The company reported quarterly net income of $89.91 million.

• Innoviva Inc shares had risen by 17.2% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 8.3% in the last three months.​

• In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy"

• Wall Street's median 12-month price target for Innoviva Inc is $35.00, about 33.1% above its last closing price of $23.42

This summary was machine generated from LSEG data February 25 at 10:53 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)